B · Normal
[Novo Nordisk: Create a new business segment called blood and endocrine diseases] Novo Nordisk’s CEO said that an additional 4,000 people were disclosed, bringing the total number of layoffs related to business integration to 13,000. The time has come to further diversify the company, with the creation of a new business segment called Hematology and Endocrine Diseases. Liver disease is also an obvious direction for our expansion. Despite recent setbacks, the cardiovascular field remains another obvious direction for expansion.
medicine 🕐 2026-09-21 16:23
#medicine #Pharmaceutical business
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Jiangsu: From January to August, the added value of industries above designated 09-22 11:22 September 21st, Novo Nordisk stated that it plans to expand its production capac 09-21 16:06 September 21st, Novo Nordisk aims to have sales of product lines under developme 09-21 16:06 [Two departments: Pilot project for electronic customs clearance of imported dru 09-21 11:28 [Pharmaceutical sector’s rally expands Huaren Pharmaceutical and more than a doz 09-21 10:43 On September 18th, Anthropic established a biological laboratory for artificial 09-18 18:19

Comments

0/500
Captcha (click to refresh)
No comments yet